InvestorsHub Logo
Followers 24
Posts 3015
Boards Moderated 0
Alias Born 01/18/2009

Re: None

Monday, 11/22/2010 10:46:59 AM

Monday, November 22, 2010 10:46:59 AM

Post# of 30369
Apricus rockets on liver cancer drug update

Nov. 22, 2010, 10:27 a.m. EST
http://www.marketwatch.com/story/apricus-rockets-on-liver-cancer-drug-update-2010-11-22

BOSTON (MarketWatch) -- Apricus Biosciences shares were on fire early Monday, rocketing on news that it has filed with U.S. regulators to conduct a Phase III clinical trial for its liver cancer medication PrevOnco. Shares of Apricus were up almost 40% at $3.77. PrevOnco is being tested on patients who are no longer responding to the widely-used liver cancer agent Nexavar, which is marketed by Bayer AG and Onyx Pharmaceuticals.

posts are IMHO // either news - with LINK

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SEEL News